EP3689365

Unitary patent

USE OF LONG-ACTING GLP-1 PEPTIDES

Filed

Jun 21, 2013

Technology

Chemistry · Pharmaceuticals

UPC cases

EPO proceedings

Ownership history

As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.

Abstract

The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.

Litigation history

Date	Case	Division	Type	Outcome	Parties
Jun 22, 2026	UPC CFI 2221/2026	Milan CD	Revocation	Locked	Sandoz AG +1

Additional proceedings on this patent

Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in